MedTrace Logo

Effect of Turmeric on Diabetic Nephropathy

NCT01015937 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2009-11-18

No results posted yet for this study

Summary

The purpose of this study is to investigate whether turmeric is effective in improvement of diabetic nephropathy and in decrease in the amount of proteinuria and cytokine levels.

Conditions

  • Diabetic Nephropathy
  • Proteinuria

Interventions

DRUG

Turmeric extract

turmeric 500 mg TID for 45 days

DRUG

Angiotensin-converting enzyme (ACE) inhibitor + Angiotensin-II type 1 receptor (ATI) blocker

maximum dosage as patient tolerated for 45 days

Sponsors & Collaborators

  • Shiraz University of Medical Sciences

    collaborator OTHER

  • Shaheed Faghihi Hospital

    lead OTHER

Principal Investigators

  • maryam pakfetrat, assistant professor · Shiraz nephro-urology research center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-06-30
Completion
2009-08-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01015937 on ClinicalTrials.gov